The enhancement of recombinant antibody production in Chinese Hamster Ovary (CHO-K1) cells is a crucial aspect of biopharmaceutical development. To maximize efficacy, various approaches are employed, including genetic engineering of the host cells and optimization of growth conditions. Moreover, integration of advanced bioreactors can significant